Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 9, 2011, Pages 1164-1169

  Bilal, Sueleyman ^a,c   Haworth, Oliver ^b   Wu, Lijun ^d   Weylandt, Karsten H ^a,c   Levy, Bruce D ^b   Kang, Jing X ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Resolvyx Pharmaceuticals   (United States)

Author keywords

Asthma; Fat 1 mice; Inflammation; Omega 3; Protectins; Resolvins

Indexed keywords

ALLERGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 9; METHACHOLINE; OMEGA 3 FATTY ACID; PROTECTIN D1; RANTES; REGULATOR PROTEIN; RESOLVIN E1; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHOSPASM; CONTROLLED STUDY; LEUKOCYTE; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CAENORHABDITIS ELEGANS PROTEINS; CHEMOKINES; CYTOKINES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACID DESATURASES; FATTY ACIDS, OMEGA-3; FEMALE; LUNG; MALE; MICE; MICE, TRANSGENIC; RESPIRATORY HYPERSENSITIVITY;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 79960557545     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.05.002     Document Type: Article

References (28)

1. Busse W.W., Lemanske R.F. Asthma. N. Engl. J. Med. 2001, 344:350-362.
2. Holgate S.T. The epidemic of allergy and asthma. Nature 1999, 402:B2-4.
3. Serhan C.N., Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 2007.
4. Serhan C.N., Yacoubian S., Yang R. Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 2008, 3:279-312.
5. Arita M., Bianchini F., Aliberti J., Sher A., Chiang N., Hong S., Yang R., Petasis N.A., Serhan C.N. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 2005, 201:713-722.
6. Bannenberg G.L., Chiang N., Ariel A., Arita M., Tjonahen E., Gotlinger K.H., Hong S., Serhan C.N. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 2005, 174:4345-4355.
7. Schwab J.M., Chiang N., Arita M., Serhan C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447:869-874.
8. Levy B.D., Kohli P., Gotlinger K., Haworth O., Hong S., Kazani S., Israel E., Haley K.J., Serhan C.N. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 2007, 178:496-502.
9. Haworth O., Cernadas M., Yang R., Serhan C.N., Levy B.D. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 2008, 9:873-879.
10. Kromann N., Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med. Scand. 1980, 208:401-406.
11. Schwartz J., Weiss S.T. The relationship of dietary fish intake to level of pulmonary function in the first National Health and Nutrition Survey. Eur. Respir. J. 1994, 7:1821-1824.
12. Yokoyama A., Hamazaki T., Ohshita A., Kohno N., Sakai K., Zhao G.D., Katayama H., Hiwada K. Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma. Int. Arch. Allergy Immunol. 2000, 123:327-332.
13. Reisman J., Schachter H.M., Dales R.E., Tran K., Kourad K., Barnes D., Sampson M., Morrison A., Gaboury I., Blackman J. Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review. BMC Complement. Altern. Med. 2006, 6:26.
14. Kang J.X., Wang J., Wu L., Kang Z.B. Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427:504.
15. Mayer K., Kiessling A., Ott J., Schaefer M.B., Hecker M., Henneke I., Schulz R., Gunther A., Wang J., Wu L., Roth J., Seeger W., Kang J.X. Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Am. J. Respir. Crit. Care Med. 2009, 179:474-483.
16. Hudert C.A., Weylandt K.H., Lu Y., Wang J., Hong S., Dignass A., Serhan C.N., Kang J.X. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11276-11281.
17. Schmocker C., Weylandt K.H., Kahlke L., Wang J., Lobeck H., Tiegs G., Berg T., Kang J.X. Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology 2007, 45:864-869.
18. Weylandt K.H., Nadolny A., Kahlke L., Kohnke T., Schmocker C., Wang J., Lauwers G.Y., Glickman J.N., Kang J.X. Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis. Biochim. Biophys. Acta 2008, 1782:634-641.
19. Kang J.X., Wang J. A simplified method for analysis of polyunsaturated fatty acids. BMC Biochem. 2005, 6:5.
20. Freedman S.D., Blanco P.G., Zaman M.M., Shea J.C., Ollero M., Hopper I.K., Weed D.A., Gelrud A., Regan M.M., Laposata M., Alvarez J.G., O'Sullivan B.P. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N. Engl. J. Med. 2004, 350:560-569.
21. Izuhara K., Arima K., Kanaji S., Ohta S., Kanaji T. IL-13: a promising therapeutic target for bronchial asthma. Curr. Med. Chem. 2006, 13:2291-2298.
22. Lopez A.F., Begley C.G., Williamson D.J., Warren D.J., Vadas M.A., Sanderson C.J. Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J. Exp. Med. 1986, 163:1085-1099.
23. Mori A., Ogawa K., Kajiyama Y., Suko M., Kaminuma O. Th2-cell-mediated chemokine synthesis is involved in allergic airway inflammation in mice. Int. Arch. Allergy Immunol. 2006, 140(Suppl 1):55-58.
24. Nicolaides N.C., Holroyd K.J., Ewart S.L., Eleff S.M., Kiser M.B., Dragwa C.R., Sullivan C.D., Grasso L., Zhang L.Y., Messler C.J., Zhou T., Kleeberger S.R., Buetow K.H., Levitt R.C. Interleukin 9: a candidate gene for asthma. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13175-13180.
25. Shen H.H., Ochkur S.I., McGarry M.P., Crosby J.R., Hines E.M., Borchers M.T., Wang H., Biechelle T.L., O'Neill K.R., Ansay T.L., Colbert D.C., Cormier S.A., Justice J.P., Lee N.A., Lee J.J. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J. Immunol. 2003, 170:3296-3305.
26. Rothenberg M.E., Hogan S.P. The eosinophil. Annu. Rev. Immunol. 2006, 24:147-174.
27. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 2006, 60:502-507.
28. Levy B.D., Bonnans C., Silverman E.S., Palmer L.J., Marigowda G., Israel E. Diminished lipoxin biosynthesis in severe asthma. Am. J. Respir. Crit. Care Med. 2005, 172:824-830.